Bioventus Inc. (BVS) Tops Q3 EPS by 4c ; Offers Guidance
Get Alerts BVS Hot Sheet
Join SI Premium – FREE
Bioventus Inc. (NASDAQ: BVS) reported Q3 EPS of $0.15, $0.04 better than the analyst estimate of $0.11. Revenue for the quarter came in at $138.7 million versus the consensus estimate of $137.65 million.
GUIDANCE:
Bioventus Inc. sees FY2025 EPS of $0.64-$0.68, versus the consensus of $0.64. Bioventus Inc. sees FY2025 revenue of $560-570 million, versus the consensus of $566.8 million.
For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Capital Securities Downgrades Full House Resorts (FLL) to Hold
- Gates Industrial Corp. (GTES) PT Lowered to $28 at Wells Fargo
- Pegatron Corp. (4938:TT) PT Raised to NT$121 at Fubon, 'Strong chance of winning SpaceX AI server orders'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share